Nagler A - Search Results

1

T-cell-depleted haploidentical stem cell transplantation results improve with time in adults with acute leukemia: A study from the Acute Leukemia Working Party of the European Society of Blood and Marrow Transplantation (EBMT).

Sestili S, Labopin M, Ruggeri A, Velardi A, Ciceri F, Maertens J, Kanz L, Aversa F, Lewalle P, Bunjes D, Mohty M, Nagler A. Sestili S, et al. Among authors: nagler a. Cancer. 2018 May 15;124(10):2142-2150. doi: 10.1002/cncr.31310. Epub 2018 Feb 22. Cancer. 2018. PMID: 29469924 Free article.

2

Non-myeloablative hematopoietic stem cell transplantation (NST) in the treatment of human malignancies: from animal models to clinical practice.

Shimoni A, Nagler A. Shimoni A, et al. Among authors: nagler a. Cancer Treat Res. 2002;110:113-36. doi: 10.1007/978-1-4615-0919-6_6. Cancer Treat Res. 2002. PMID: 11908195 Review.

3

Treatment of leukemia by alloreactive lymphocytes and nonmyeloablative stem cell transplantation.

Slavin S, Nagler A, Shapira MY, Aker M, Gabriel C, Or R. Slavin S, et al. Among authors: nagler a. J Clin Immunol. 2002 Mar;22(2):64-9. doi: 10.1023/a:1014423617596. J Clin Immunol. 2002. PMID: 11998894 Review.

4

Successful major surgical recovery of a patient following haploidentical stem cell transplantation for chronic myeloid leukemia in blast crisis and aspergillosis.

Varadi G, Svirsky O, Nagler A. Varadi G, et al. Among authors: nagler a. Acta Haematol. 2002;108(1):29-32. doi: 10.1159/000063056. Acta Haematol. 2002. PMID: 12145464

5

Kröger N, Sayer HG, Schwerdtfeger R, Kiehl M, Nagler A, Renges H, Zabelina T, Fehse B, Ayuk F, Wittkowsky G, Schmitz N, Zander AR. Kröger N, et al. Among authors: nagler a. Blood. 2002 Dec 1;100(12):3919-24. doi: 10.1182/blood-2002-04-1150. Epub 2002 Aug 8. Blood. 2002. PMID: 12393448 Free article. Clinical Trial.

6

Nonmyeloablative allogeneic stem cell transplantation for the treatment of chronic myeloid leukemia in first chronic phase.

Or R, Shapira MY, Resnick I, Amar A, Ackerstein A, Samuel S, Aker M, Naparstek E, Nagler A, Slavin S. Or R, et al. Among authors: nagler a. Blood. 2003 Jan 15;101(2):441-5. doi: 10.1182/blood-2002-02-0535. Epub 2002 Sep 19. Blood. 2003. PMID: 12393604 Free article.

7

Intravenous busulfan-based conditioning prior to allogeneic hematopoietic stem cell transplantation: myeloablation with reduced toxicity.

Shimoni A, Bielorai B, Toren A, Hardan I, Avigdor A, Yeshurun M, Ben-Bassat I, Nagler A. Shimoni A, et al. Among authors: nagler a. Exp Hematol. 2003 May;31(5):428-34. doi: 10.1016/s0301-472x(03)00047-x. Exp Hematol. 2003. PMID: 12763142 Free article.

8

Hematopoietic stem-cell transplantation using umbilical-cord blood.

Cohena Y, Nagler A. Cohena Y, et al. Among authors: nagler a. Leuk Lymphoma. 2003 Aug;44(8):1287-99. doi: 10.1080/1042819031000077016. Leuk Lymphoma. 2003. PMID: 12952221 Review.

9

Cord blood biology and transplantation.

Cohen Y, Nagler A. Cohen Y, et al. Among authors: nagler a. Isr Med Assoc J. 2004 Jan;6(1):39-46. Isr Med Assoc J. 2004. PMID: 14740509 Free article. Review.

10

Clinical implications of minimal residual disease monitoring for stem cell transplantation after reduced intensity and nonmyeloablative conditioning.

Shimoni A, Nagler A. Shimoni A, et al. Among authors: nagler a. Acta Haematol. 2004;112(1-2):93-104. doi: 10.1159/000077564. Acta Haematol. 2004. PMID: 15179009 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,461 results

Search Page

Filters